Wearable arm band for amplified musculoskeletal pain syndrome in children
Part of Pain clinical trials.
This study tests a wearable device called Nerivio that uses a gentle arm band to help reduce pain in children with amplified musculoskeletal pain syndrome (AMPS). The goal is to see if it safely eases pain and improves daily functioning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 8 and 18 years old.
- Your child must have a confirmed diagnosis of AMPS (amplified musculoskeletal pain syndrome) from a pediatric pain specialist.
- Your child must have had muscle or joint pain for at least 3 months, and rate their average pain as at least 4 out of 10.
- You need a compatible smartphone or device to run the Nerivio app.
- Your child must not have certain conditions (like autoimmune disease, implanted medical devices, or severe mood disorders) and cannot be pregnant.
- You must be able to commit to a 4-week treatment and data collection period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a wearable device that gives gentle vibrations (called Apollo Neuro) can help reduce self-harming behaviors in children with autism. If your child has autism and often hurts themselves, this device might be a drug-free way to help them feel calmer and safer.
This study tests a new wearable device that uses mild electrical pulses to treat chronic pain in the knee, arm, or shoulder. It is for people whose pain started after surgery or injury and who have not found enough relief with standard treatments.
This study tests a wearable device that uses gentle electrical signals to reduce pain in people with migraine or fibromyalgia. It may help by changing how the brain processes pain signals.
This trial tests whether a small non-surgical device can help keep children with steroid-sensitive nephrotic syndrome in remission. If it works, it could lower the chance of relapse (kidney flare-ups) and help maintain kidney health.
This trial tests whether a nerve-stimulation treatment can reduce chronic neck and upper arm pain when other treatments haven’t worked. It includes adults who can consent and attend follow-up visits, and it checks for safety with pregnancy prevention and a specific early test after implantation.
This Phase 2 study looks at how spinal cord (or nerve-root) stimulation affects pain signals in the brain and body. You may qualify if you already have a stimulator set to a comfort mode that avoids “tingling” sensations.
Hear when a new Amplified Musculoskeletal Pain Syndrome (AMPS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.